VENTOLIN ACCUHALER 200 mcginhalation

Država: Singapur

Jezik: angleščina

Source: HSA (Health Sciences Authority)

Aktivna sestavina:

SALBUTAMOL SULPHATE EQV SALBUTAMOL

Dostopno od:

GLAXOSMITHKLINE PTE LTD

Koda artikla:

R03AC02

Odmerek:

200 mcg/inhalation

Farmacevtska oblika:

POWDER, METERED

Sestava:

SALBUTAMOL SULPHATE EQV SALBUTAMOL 200 mcg/inhalation

Pot uporabe:

RESPIRATORY (INHALATION)

Tip zastaranja:

Prescription Only

Izdeluje:

GLAXO WELLCOME PRODUCTION

Status dovoljenje:

ACTIVE

Datum dovoljenje:

1997-07-31

Navodilo za uporabo

VENTOLIN™ ACCUHALER™ 
SALBUTAMOL 

 QUALITATIVE AND QUANTITATIVE COMPOSITION 

_VENTOLIN _Accuhaler is a moulded plastic device containing a
foil strip with 60 regularly 
distributed blisters. Each blister contains a powder blend of 200
micrograms of 
salbutamol (as sulphate) and lactose. 

The device incorporates a dose counter which displays the
number of doses remaining 
in the device. 

PHARMACEUTICAL FORM 

Inhalation powder 

CLINICAL PARTICULARS 
INDICATIONS 

_VENTOLIN _Accuhaler can be used in the management of reversible
airways 
obstruction.It is particularly suitable for the relief of asthma
symptoms. It should be used 
to relieve symptoms when they occur and to prevent them in
those circumstances 
recognised by the patient to precipitate an
asthmatic attack (e.g. before exercise or 
unavoidable allergen exposure). 

_VENTOLIN _Accuhaler is particularly valuable
as relief medication in mild, moderate or 
severe asthma, provided that reliance on it does not delay the
introduction and use of 
regular inhaled corticosteroid therapy. 

Salbutamol is a selective beta
2
 adrenoceptor agonist indicated for the treatment or 
prevention
of bronchospasm. It provides short acting (four hours) bronchodilation
in 
reversible airways obstruction. For patients with asthma
salbutamol may be used to 
relieve symptoms when they occur and to prevent them prior to a
known trigger. 

Bronchodilators should not be the only or main treatment in
patients with persistent 
asthma. In patients with persistent asthma unresponsive
to _VENTOLIN_, treatment with 
inhaled corticosteroids is recommended to achieve and maintain
control. Failing to 
respond to treatment with _VENTOLIN_ may signal a need
for urgent medical advice or 
treatment. 

DOSAGE AND ADMINISTRATION 
_VENTOLIN_ has a duration of action
of 4 to 6 hours in most pati

Lastnosti izdelka

VENTOLIN™ ACCUHALER™
SALBUTAMOL
QUALITATIVE AND QUANTITATIVE COMPOSITION
_VENTOLIN _Accuhaler is a moulded plastic device containing a foil
strip with 60 regularly
distributed blisters. Each blister contains a powder blend of 200
micrograms of
salbutamol (as sulphate) and lactose.
The device incorporates a dose counter which displays the number of
doses remaining
in the device.
PHARMACEUTICAL FORM
Inhalation powder
CLINICAL PARTICULARS
INDICATIONS
_VENTOLIN _Accuhaler can be used in the management of reversible
airways
obstruction.It is particularly suitable for the relief of asthma
symptoms. It should be used
to relieve symptoms when they occur and to prevent them in those
circumstances
recognised by the patient to precipitate an asthmatic attack (e.g.
before exercise or
unavoidable allergen exposure).
_VENTOLIN _Accuhaler is particularly valuable as relief medication in
mild, moderate or
severe asthma, provided that reliance on it does not delay the
introduction and use of
regular inhaled corticosteroid therapy.
Salbutamol is a selective beta-
2
adrenoceptor agonist indicated for the treatment or
prevention of bronchospasm. It provides short acting (four hours)
bronchodilation in
reversible airways obstruction. For patients with asthma salbutamol
may be used to
relieve symptoms when they occur and to prevent them prior to a known
trigger.
Bronchodilators should not be the only or main treatment in patients
with persistent
asthma. In patients with persistent asthma unresponsive to _VENTOLIN_,
treatment with
inhaled corticosteroids is recommended to achieve and maintain
control. Failing to
respond to treatment with _VENTOLIN_ may signal a need for urgent
medical advice or
treatment.
DOSAGE AND ADMINISTRATION
_VENTOLIN_ has a duration of action of 4 to 6 hours in most patients.
Increasing use of beta-
2
agonists may be a sign of worsening asthma. Under these
conditions a reassessment of the patient's therapy plan may be
required and
concomitant glucocorticosteroid therapy should be considered.
As there may be